Tibet Aim Pharm (SZSE:002826) Cash Flow for Dividends : ¥-19.9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm Cash Flow for Dividends?

Tibet Aim Pharm's cash flow for dividends for the three months ended in Mar. 2024 was ¥-0.1 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-19.9 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Tibet Aim Pharm's quarterly payment of dividends declined from Sep. 2023 (¥-19.2 Mil) to Dec. 2023 (¥-0.1 Mil) and declined from Dec. 2023 (¥-0.1 Mil) to Mar. 2024 (¥-0.1 Mil).

Tibet Aim Pharm's annual payment of dividends increased from Dec. 2020 (¥-9.3 Mil) to Dec. 2021 (¥-16.1 Mil) and increased from Dec. 2021 (¥-16.1 Mil) to Dec. 2022 (¥-19.8 Mil).

Tibet Aim Pharm Cash Flow for Dividends Historical Data

The historical data trend for Tibet Aim Pharm's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Aim Pharm Cash Flow for Dividends Chart

Tibet Aim Pharm Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash Flow for Dividends

Get a 7-Day Free Trial

-12.76

-8.40

-9.29

-16.10

-19.77

Tibet Aim Pharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-0.46	-0.47	-19.20	-0.15	-0.10

Tibet Aim Pharm Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-19.9 Mil.

Tibet Aim Pharm Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Aim Pharm (SZSE:002826) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » Cash Flow for Dividends

Traded in Other Exchanges

N/A

Address

No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000

Website

http://www.emyy.cn

Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.

Executives

Peng Hui	Director
Pang Guo Qiang	Directors, executives
Li Qian Jin	Securities Affairs Representative
Liu Hang	Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines